ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RGC vs BTI // FREE CASH FLOW YIELD

Regencell Bioscience Holdings Limited (NASDAQ) VS. British American Tobacco Industries p.l.c. ADR (NYSE) • 15-METRIC TALLY: RGC 0 — BTI 4
▲ FREE CASH FLOW YIELD LEADER: BTI
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RGC VS. BTI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RGC BTI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 9.90% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 21.0x — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -0.10% 2.21% -2.31 BTI /fcf-yield <GO>
Operating Margin — 13.90% — TIE /operating-margins <GO>
Net Profit Margin — 10.90% — TIE /net-margins <GO>
Revenue Growth (YoY) — 0.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 3.74 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 7/9 -5.00 BTI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.1 65.7 -21.60 BTI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.05 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 30.5x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.40B $131.93B -$128.53B BTI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RGC REV BTI REV RGC GROSS % BTI GROSS % RGC FCF BTI FCF
FY 2025 $0 — — — -$3.3M —
FY 2024 $0 — — — -$4.0M —
FY 2023 $0 — — — -$5.0M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RGC // BETA —
BTI // BETA 1.05